The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $55.56

Today's change+0.43 +0.78%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $55.56

Today's change+0.43 +0.78%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

PAREXEL International Corp up (U.S.)$0.43

PAREXEL International Corp closed up Friday by (U.S.)$0.43 or 0.78% to (U.S.)$55.56. Over the last five days, shares have gained 2.64% and 22.97% year to date. Shares have outperformed the S&P 500 by 17.45% during the last year.

Key company metrics

  • Open(U.S.) $55.02
  • Previous close(U.S.) $55.13
  • High(U.S.) $55.98
  • Low(U.S.) $54.46
  • Bid / Ask-- / --
  • YTD % change+22.97%
  • Volume982,102
  • Average volume (10-day)844,378
  • Average volume (1-month)668,061
  • Average volume (3-month)767,140
  • 52-week range(U.S.) $41.52 to (U.S.) $64.72
  • Beta0.96
  • Trailing P/E22.46×
  • P/E 1 year forward20.68×
  • Forward PEG1.21×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.47
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.07%

Based on its net profit margin of 6.07%, PAREXEL International Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue574585578574
Total other revenue--------
Total revenue574585578574
Gross profit174185171163
Total cost of revenue400400407411
Total operating expense520526526528
Selling / general / administrative991039796
Research & development--------
Depreciation / amortization20212120
Interest expense (income), net operating--------
Unusual expense (income)--000
Other operating expenses, total--------
Operating income54595247
Interest income (expense), net non-operating-2-2-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax55565043
Income after tax37403528
Income tax, total18161515
Net income37403528
Total adjustments to net income--------
Net income before extra. items37403528
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items37403528
Inc. avail. to common incl. extra. items37403528
Diluted net income38403528
Dilution adjustment1--0--
Diluted weighted average shares56575857
Diluted EPS excluding extraordinary itemsvalue per share0.680.700.600.49
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.680.690.600.49